Preferred Name |
Atazanavir |
|
Synonyms |
ATAZANAVIR Atazanavir |
|
Definitions |
An aza-dipeptide analogue with a bis-aryl substituent on the (hydroxethyl)hydrazine moiety with activity against both wild type and mutant forms of HIV protease. Atazanavir does not elevate serum lipids, a common problem with other protease inhibitors. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C66872 |
|
CAS_Registry |
198904-31-3 |
|
CHEBI_ID |
CHEBI:37924 |
|
Chemical_Formula |
C38H52N6O7 |
|
code |
C66872 |
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173381 |
|
Contributing_Source |
FDA |
|
DEFINITION |
An aza-dipeptide analogue with a bis-aryl substituent on the (hydroxethyl)hydrazine moiety with activity against both wild type and mutant forms of HIV protease. Atazanavir does not elevate serum lipids, a common problem with other protease inhibitors. |
|
FDA_UNII_Code |
QZU4H47A3S |
|
FULL_SYN |
ATAZANAVIR Atazanavir |
|
Has_Salt_Form | ||
label |
Atazanavir |
|
Legacy Concept Name |
Atazanavir_Base |
|
Preferred_Name |
Atazanavir |
|
prefixIRI |
Thesaurus:C66872 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C1145759 |
|
subClassOf |